Search clinical trials for: Warfarin; Dantonic

Total 515 results

Johns Hopkins University

Completed

Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation

Atrial Fibrillation | Bradycardia | Tachycardia | Valvular Heart Disease

United States
Bial - Portela C S.A.

Completed

Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Healthy

Portugal
Boehringer Ingelheim

Completed

Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers

Healthy
University of Alberta
Heart and Stroke Foundation of Canada; Canadian Stroke Prevention Intervention...

Completed

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing (PIAAFRx)

Stroke | Atrial Fibrillation

Canada
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis

Thrombosis

Turkey
Intermountain Health Care, Inc.

Completed

Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin (Coumagen-II)

Thromboembolism

United States
Hamilton Health Sciences Corporation

Completed

Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

Thrombosis | Bleeding | End Stage Renal Disease

Canada
Chinese University of Hong Kong
Professor Bryan Ping Yen YAN (byan)

Recruiting

Warfarin Dosage Adjustment Model Analysis Study

Warfarin

Hong Kong
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects

Healthy
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves

Pregnancy | Heart; Complications, Valve, Prosthesis

Turkey
Wuhan Asia Heart Hospital

Unknown

AI-based Social Software to Manage wARfarin Therapy (AI-SMART)

Anticoagulant-induced Bleeding | Warfarin Sodium Causing Adverse Effects in Therapeutic Use

China
First Affiliated Hospital Xi'an Jiaotong University

Withdrawn

Gene-guided Warfarin for Anticoagulation Therapy (GWAT)

Stroke
University of Padova

Completed

Early Identification of Warfarin Maintenance Dosage

Atrial Fibrillation

Italy
ARYx Therapeutics

Unknown

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation (EmbraceAC)

Myocardial Infarction | Atrial Fibrillation | Atrial Flutter | Cardiomyopathy | Venous Thromboembolic Disease

United States
University Hospital, Bonn
German Research Foundation; German Federal Ministry of Education and Research

Unknown

D-Dimer Guided Oral Anticoagulant Treatment (OAT) (DDOAT2006)

Deep Venous Thrombosis

Germany
Cedars-Sinai Medical Center
National Institute on Aging (NIA)

Recruiting

A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF (APOTHECARYAF)

Stroke | Atrial Fibrillation

United States
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

The Study of Warfarin Maintenance Dose in Chinese Patients (WADCH)

Atrial Fibrillation | Heart Valve Disease | Pulmonary Artery Embolism

China
University of North Carolina, Chapel Hill
UNC Institute for Pharmacogenomics and Individualized Therapy

Completed

Genotype-Guided Warfarin Therapy Trial (WARFPGX)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism | Artificial Heart Valve

United States
AstraZeneca

Completed

Long-term Safety in Atrial Fibrillation Patients

Persistent or Permanent Nonvalvular Atrial Fibrillation
Woman's Health University Hospital, Egypt

Terminated

Warfarine in Unexplained Oligohydramnios

Oligohydramnios

Egypt
Fundació Institut de Recerca de l'Hospital de la...

Completed

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding. (HEPACO)

Acute Gastrointestinal Bleeding

Spain
Intermountain Health Care, Inc.
Deseret Foundation; LDS Hospital Cardiovascular Research

Completed

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

United States
University of Alberta

Completed

Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial

Anticoagulation

Canada
Hamilton Health Sciences Corporation
The Physicians' Services Incorporated Foundation

Completed

Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients

Venous Thrombosis | Atrial Fibrillation | Heart Valve Diseases

Canada
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

A Study to Determine the Effects of Multiple Doses of Mipomersen (200 mg SC) on the Pharmacodynamics and Pharmacokinetics of Single-dose Warfarin

Healthy

United States
University of Utah
Roche Diagnostics

Completed

Fearon Algorithm in Warfarin Patient Self-Management

Atrial Fibrillation | Heart Valve Diseases | Venous Thromboses

United States
Novo Nordisk A/S

Completed

Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment

Healthy | Haemostasis

United States
Pfizer

Completed

The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Urinary Bladder, Overactive

United States
Medco Health Solutions, Inc.
Mayo Clinic; Washington University School of Medicine

Completed

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings (MHSMayoWarf1)

Vascular Diseases | Embolism | Embolism and Thrombosis | Thrombosis | Thromboembolism | Venous Thromboembolism | Warfarin

United States
Montreal Heart Institute
Roche Diagnostic Ltd.

Completed

Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy (ESCAPE)

Quality of Life | Anticoagulants | Drug Monitoring | Pharmacy | Ambulatory Care

Canada
Novo Nordisk A/S

Completed

Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Germany
University of Texas Southwestern Medical Center

Withdrawn

Biological Effect of Warfarin on Pancreatic Cancer

Pancreatic Cancer

United States
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism

COPD Exacerbation | PTE - Pulmonary Thromboembolism

China
University of Campania "Luigi Vanvitelli"
Federico II University; University of Salerno

Unknown

Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity (VIALE)

Atrial Fibrillation | Thrombus Due to Heart Valve Prosthesis

Italy
The Cooper Health System

Completed

Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

Metachromatic Leukodystrophy

United States
Azienda Ospedaliera Universitaria Policlinico

Completed

Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants (DACUS)

Deep Vein Thrombosis
The First Affiliated Hospital with Nanjing Medical...

Completed

LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke (5A)

Stroke | Atrial Fibrillation | Systemic Embolism

China
University of British Columbia

Completed

Warfarin Patient Self-Monitoring

Atrial Fibrillation

Canada
The First Affiliated Hospital with Nanjing Medical...

Unknown

The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

Atrial Fibrillation

China
Institute for Clinical and Experimental Medicine
Abbott

Unknown

MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)

Cardiovascular Diseases | Heart Failure
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

Cardiovascular Diseases | Venous Thrombosis | Venous Thromboembolism
Melinta Therapeutics, Inc.

Completed

Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects

Healthy

United States
Institute for Clinical and Experimental Medicine
Abbott

Unknown

Anti-thrombotic Monotherapy With the HeartMate 3 LVAS

Cardiovascular Diseases | Heart Failure

Czechia
University of Chicago
Agency for Healthcare Research and Quality (AHRQ)

Completed

Clinical and Economic Implications of Genetic Testing for Warfarin Management

Blood Coagulation Disorders

United States
Hadassah Medical Organization
Ministry of Health, Israel; Israel Science Foundation; United States - Israel...

Unknown

Genetic Determinants of Warfarin Anticoagulation Effect

Venous Thrombosis | Atrial Fibrillation | Pulmonary Embolism

Israel
Astellas Pharma Inc

Completed

A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery (PEARL)

Arthroplasty, Replacement, Knee

United States, Canada
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Warfarin and PA21

Drug Interaction Potentiation

United States
Università degli Studi dell'Insubria

Terminated

D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

Venous Thromboembolism

Italy
Anand, Sonia, M.D.
Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...

Unknown

Warfarin and Antiplatelet Vascular Evaluation

Cardiovascular Diseases | Peripheral Vascular Diseases

Canada
University of Washington

Completed

Effectiveness of Pressure Garment Therapy After Burns

Hypertrophic Scarring After Burn Injury

United States

Search clinical trials for: Warfarin; Dantonic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations